Abstract

Nearly 100 years ago, Ashworth 2 reported the finding of cancer cells in the blood of a dead patient similar to those of the patient's malignant skin tumor. In 1934, Pool and Dunlop 11 studied the systemic blood of patients with cancer for presence of neoplastic cells, and Engell 5 in 1955 discovered tumor cells in the peripheral blood of patients with resectable and unresectable neoplasms. In the last 4 to 5 years, because of the development of new cytologic methods, more reports have appeared in the literature on the presence of cancer cells in the blood of patients with resectable neoplasm. This led to the use of chemotherapeutic agents at the time of surgery in an attempt to affect the cancer cells in the systemic circulation. 10,13 In our laboratory we have been investigating the effects of alteration of the clotting mechanism on the production of tumor metastases. Fibrinolysin

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.